MC38 murine colon cancer [28] were previously characterized as responders to anti-PD-1 therapies [21], and murine melanoma B16-hCXCR4 previously defined as poor immune responsive tumors [22, 24, 29]. This evidence concerns the gene PDCD1 and melanoma.